Description

Zepbound is the brand name for tirzepatide, a once‑weekly injectable medication approved by the U.S. Food and Drug Administration for chronic weight management in adults with obesity or adults with overweight who have at least one weight‑related condition.

What is Zepbound?

Zepbound contains tirzepatide, a dual glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1) receptor agonist. It was developed to support significant weight reduction when used alongside a reduced‑calorie diet and increased physical activity. It contains tirzepatide, a prescription-only medication that can be used for 2 conditions: weight loss and type 2 diabetes. It comes in the form of an injectable pen, containing 4 doses you inject yourself once per week at around the same time.

Zepbound is only prescribed for weight loss and is the brand name for tirzepatide in the USA. It’s manufactured by the same company that makes Mounjaro.

How does Zepbound work?

Tirzepatide targets appetite regulation and metabolic pathways by activating GIP and GLP‑1 receptors, which can reduce hunger, slow gastric emptying, and improve blood sugar control. Zepbound’s active ingredient, tirzepatide, mimics 2 hormones that are usually released after eating, called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

These are both a type of incretin hormone, working in 3 main ways:

1. Slowing down the rate at which you digest food to keep you feeling full for longer.
2. Signalling to your brain that you’re full, lowering appetite.
3. Regulating blood sugar by increasing insulin levels.

As tirzepatide mimics these hormones, the same receptors in your body are triggered, tricking your body into carrying out the same actions. When you take Zepbound (or Mounjaro) week after week, you should notice you feel less hungry, can eat less, and feel full after eating and between meals. If you also have conditions like prediabetes, it could help to improve your blood sugar levels and reduce cravings caused by spiking sugar levels.

Zepbound dosage schedule

Zepbound is prescribed at the lowest dose of tirzepatide: 2.5mg for 4 weeks. You’ll then increase the dosage every 4 weeks, although you can choose to stay on a lower dose for longer if you need more time to get used to the treatment, or if it’s working well for you at a lower dose.

Key Benefits and Clinical Results

• Significant weight loss potential when combined with lifestyle changes.
• Once‑weekly dosing for convenience and adherence.
• Dual metabolic effects that may also improve markers related to type 2 diabetes and cardiometabolic risk.

Safety, and Who Should Consider Zepbound

Patients should discuss their medical history, current medications, and pregnancy plans with a healthcare provider before starting Zepbound. It’s indicated as part of a comprehensive weight‑management plan that includes diet and exercise.

FAQ

• What is Zepbound used for
  Zepbound is used for chronic weight management in adults with obesity or overweight plus at least one weight‑related condition, alongside diet and exercise.
• How often is Zepbound given
  Zepbound is administered once weekly as an injection.
• Is Zepbound the same as Mounjaro
  The active molecule, tirzepatide, is the same compound used in other indications; Zepbound is the brand name for chronic weight management.